ncRNA Study in Males with Breast Cancer
Abstract
Male breast cancer (BC) is a rare disease accounting for less than 1% of all BC detected. For this reason, it would be important to find ways to prevent this kind of cancer, to know how it develops in men and if there is any genetic predisposition to have BC. We know that noncoding RNA (ncRNA) are involved in female breast cancer but there is no information about their role in males. In this paper we try to find if some ncRNA have implications in male BC. Specifically, we have studied some single nucleotide polymorphisms of the genes encoding for mir-146A, mir-196A2, mir-499A and long noncoding RNA, HotAIR. The technique used was genotyping with taqman probe, that allows to discriminate between different polymorphisms. The genetic counsil of cancer research center provides us with the study population. The preliminary results showed that the allele C of the polymorphism with rs2910164 of the mir-146A gene and the genotype CA of the polymorphism with rs1899663 of the HotAIR gene could protect males from developing BC.
- Referencias
- Cómo citar
- Del mismo autor
- Métricas
Banco de ADN. Grupo de trabajo de Banco de ADN del instituto de salud Carlos III, PNT extracción de ácidos nucleicos (2011), Pág: 12-13, Disponible en: https://redbiobancos.es/wp-content/uploads/pnt-extraccion-acidos-nucleicos.pdf
Bayram S., Sümbul A.T. y Dada? E., A funtional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study. Tumor Biol. (2016); 37(4):5577-84. DOI: 10.1007/s13277-015-4430-y
Catucci I., Yang R., Verderio P., Pizzamiglio S., Heesen L., Hemminki K., Sutter C., Wappenschmidt B., Dick M., Arnold N., Bugert P., Niederacher D., Meindl A., Schmutzler R.K., Bartram C.C., Ficarazzi F., Tizzoni L., Zaffaroni D., Manoukian S., Barile M., Pierotti M.A., Radice P., Burwinkel B., Peterlongo P., Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat. (2010); 31(1):E1052-7. DOI: 10.1002/humu.21141
Collins L.J., Schönfeld B., Chen X.S., Handobook of epigenetics (2011); Pág: 49-61, Chapter4 – the epidenetics of non-codingRNA, DOI: 10.1016/B978-0-12-375709-8.00004-6
Dai Z.M., Kang H.F., Zhang W.G., Li H.B., Zhang S.Q., Ma X.B., Lin S., Wang M., Feng Y.J., Liu K., Liu X.H., Xu P., Dai Z.J., The Associations of Single Nucleotide Polymorphisms in miR196a2, miR-499, and miR-608 With Breast Cancer Susceptibility: A STROBE-Compliant Observational Study. Medicine (Baltimore). (2016); 95(7):e2826. DOI: 10.1097/MD.0000000000002826
Hu Z., Liang J., Wang Z., Tian T., Zhou X., Chen J., Miao R., Wang Y., Wang X., Shen H., Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat. (2009); 30(1):79-84. DOI: 10.1002/humu.20837
Jeffares, D., Poole, A. y Penny, D. J Mol Evol (1998); 46: 18. DOI: 10.1007/PL00006280
Li J., Liu R., Tang S., Feng F., Wang X., Qi L., Liu C., Yao Y., Sun C., The effect of long noncoding RNAs HOX transcript antisense intergenic RNA single-nucleotide polymorphisms on breast cancer, cervical cancer, and ovarian cancer susceptibility: A meta-analysis. J Cell Biochem. (2018); 28. DOI: 10.1002/jcb.27975.
PATIA ¿En qué consiste el genotipado? [Internet], Patia diabetes, (8 marzo 2016) [consultado 22 enero 2019] Disponible en: http://www.patiadiabetes.com/faq-items/consiste-genotipado/
Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. (2016); 28;1:15004. DOI: 10.1038/sigtrans.2015.4.
Tang Q., Hann S. S., HOTAIR: An Oncogenic Long Non-Coding RNA in Human Cancer, Cell Physiol Biochem (2018); 47:893-913 DOI: 10.1159/000490131
Upadhyaya K., Smith R.A., Chacon-Cotes D., Revêchon G., Bellis C., Lea R.A., Haupt L.M., Chambers S.K., Youl P. H., Griffiths L.R., Association of the microRNA-Single Nucleotide Polymorphism rs2910164 in miR146a with sporadic breast cancer susceptibility: A case control study, Gene (2016); 576, 256-260. DOI: 10.1016/j.gne.2015.10.019
Vieira, F.M.J., Porfiria cutânea tardia com mutações do gene da hemocromatose C282Y e H63D e análise retrospectiva do perfil de ferro em relação ao tratamento: estudo de 60 casos [tesis]. São Paulo: Faculdade de Medicina; (2012) [acceso 2020-1-23]. Disponible en: http://www.teses.usp.br/teses/disponiveis/5/5133/tde-24012013-170707/.
What is epigenetics?, non-coding RNA [Internet], What is epigenetics?, [Consultado 26 de enero 2019] Disponible en: https://www.whatisepigenetics.com/non-coding-rna/
Zhang L.H., Hao B.B., Zhang C.Y., Dai X.Z. and Zhang F., Contributions of polymorphisms in miR146a, miR196a, and miR499 to the development of hepatocellular carcinoma, Genet. Mol. Res. (2016); 15: 3, DOI: 10.4238/gmr.15038582
Bayram S., Sümbul A.T. y Dada? E., A funtional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study. Tumor Biol. (2016); 37(4):5577-84. DOI: 10.1007/s13277-015-4430-y
Catucci I., Yang R., Verderio P., Pizzamiglio S., Heesen L., Hemminki K., Sutter C., Wappenschmidt B., Dick M., Arnold N., Bugert P., Niederacher D., Meindl A., Schmutzler R.K., Bartram C.C., Ficarazzi F., Tizzoni L., Zaffaroni D., Manoukian S., Barile M., Pierotti M.A., Radice P., Burwinkel B., Peterlongo P., Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat. (2010); 31(1):E1052-7. DOI: 10.1002/humu.21141
Collins L.J., Schönfeld B., Chen X.S., Handobook of epigenetics (2011); Pág: 49-61, Chapter4 – the epidenetics of non-codingRNA, DOI: 10.1016/B978-0-12-375709-8.00004-6
Dai Z.M., Kang H.F., Zhang W.G., Li H.B., Zhang S.Q., Ma X.B., Lin S., Wang M., Feng Y.J., Liu K., Liu X.H., Xu P., Dai Z.J., The Associations of Single Nucleotide Polymorphisms in miR196a2, miR-499, and miR-608 With Breast Cancer Susceptibility: A STROBE-Compliant Observational Study. Medicine (Baltimore). (2016); 95(7):e2826. DOI: 10.1097/MD.0000000000002826
Hu Z., Liang J., Wang Z., Tian T., Zhou X., Chen J., Miao R., Wang Y., Wang X., Shen H., Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat. (2009); 30(1):79-84. DOI: 10.1002/humu.20837
Jeffares, D., Poole, A. y Penny, D. J Mol Evol (1998); 46: 18. DOI: 10.1007/PL00006280
Li J., Liu R., Tang S., Feng F., Wang X., Qi L., Liu C., Yao Y., Sun C., The effect of long noncoding RNAs HOX transcript antisense intergenic RNA single-nucleotide polymorphisms on breast cancer, cervical cancer, and ovarian cancer susceptibility: A meta-analysis. J Cell Biochem. (2018); 28. DOI: 10.1002/jcb.27975.
PATIA ¿En qué consiste el genotipado? [Internet], Patia diabetes, (8 marzo 2016) [consultado 22 enero 2019] Disponible en: http://www.patiadiabetes.com/faq-items/consiste-genotipado/
Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. (2016); 28;1:15004. DOI: 10.1038/sigtrans.2015.4.
Tang Q., Hann S. S., HOTAIR: An Oncogenic Long Non-Coding RNA in Human Cancer, Cell Physiol Biochem (2018); 47:893-913 DOI: 10.1159/000490131
Upadhyaya K., Smith R.A., Chacon-Cotes D., Revêchon G., Bellis C., Lea R.A., Haupt L.M., Chambers S.K., Youl P. H., Griffiths L.R., Association of the microRNA-Single Nucleotide Polymorphism rs2910164 in miR146a with sporadic breast cancer susceptibility: A case control study, Gene (2016); 576, 256-260. DOI: 10.1016/j.gne.2015.10.019
Vieira, F.M.J., Porfiria cutânea tardia com mutações do gene da hemocromatose C282Y e H63D e análise retrospectiva do perfil de ferro em relação ao tratamento: estudo de 60 casos [tesis]. São Paulo: Faculdade de Medicina; (2012) [acceso 2020-1-23]. Disponible en: http://www.teses.usp.br/teses/disponiveis/5/5133/tde-24012013-170707/.
What is epigenetics?, non-coding RNA [Internet], What is epigenetics?, [Consultado 26 de enero 2019] Disponible en: https://www.whatisepigenetics.com/non-coding-rna/
Zhang L.H., Hao B.B., Zhang C.Y., Dai X.Z. and Zhang F., Contributions of polymorphisms in miR146a, miR196a, and miR499 to the development of hepatocellular carcinoma, Genet. Mol. Res. (2016); 15: 3, DOI: 10.4238/gmr.15038582
Díez Castro, D., Ovejero Sánchez, M., & González Sarmiento, R. (2021). ncRNA Study in Males with Breast Cancer. FarmaJournal, 6(1), 27–37. https://doi.org/10.14201/fj2021612737
Most read articles by the same author(s)
- Ana María Mateos Temprano, Rogelio González Sarmiento, Taxol Effect in Autophagy of Colon Cancer Cells , FarmaJournal: Vol. 2 No. 1 (2017)
- Tomás González Cabero, Rogelio González Sarmiento, Study of Genetic Susceptibility to Age-related Macular Degeneration , FarmaJournal: Vol. 5 No. 2 (2020)
- Carmen Sánchez Arroyo, Rogelio González Sarmiento, Study of autophagy inhibitors and epigenetic drugswithin a cellular line of prostate cancer , FarmaJournal: Vol. 2 No. 2 (2017)
Similar Articles
- Marina Rosón, Rogelio González, Non-coding RNA polymorphisms research in Hereditary breast and ovarian cancer syndrome , FarmaJournal: Vol. 5 No. 2 (2020)
- Claudia Orallo, Rogelio Gonzalez-Sarmiento, Evaluation of chloroquine effect in autophagy of breast cancer cells and its possible use in chemotherapy , FarmaJournal: Vol. 1 No. 1 (2016)
- Raquel Francés Caminero, Ramona Mateos Campos, Systematic review of cancer research treatments , FarmaJournal: Vol. 6 No. 1 (2021)
- Sofía Garzón, María Paz Valverde, Pharmaceutical Care of Patients with Non-Small Cell Lung Cancer Treated with Osimertinib , FarmaJournal: Vol. 11 No. 1 (2026)
- Carmen Sánchez Arroyo, Rogelio González Sarmiento, Study of autophagy inhibitors and epigenetic drugswithin a cellular line of prostate cancer , FarmaJournal: Vol. 2 No. 2 (2017)
- Alfonso Torices, Carmen Guerrero, Terapia antiplaquetaria en cáncer , FarmaJournal: Vol. 6 No. 2 (2021)
- Ana María Mateos Temprano, Rogelio González Sarmiento, Taxol Effect in Autophagy of Colon Cancer Cells , FarmaJournal: Vol. 2 No. 1 (2017)
- Javier Iglesias Colino, David García González, Miriam Flores Fernández, Pilar González Pérez, Miguel García Sanz, Alejandro Sanz Ruiz, Juan José Ortiz De Urbina González, Therapeutic drug monitoring of serum concentrations of abiraterone , FarmaJournal: Vol. 11 No. 1 (2026)
- Ana Hernández Guio, Aránzazu Zarzuelo Castañeda, Almudena Sánchez Martín, Skin care in patients with cancer , FarmaJournal: Vol. 2 No. 2 (2017)
- Alicia Abril, Javier Tascón, Laura Vicente-Vicente, Alfredo G. Casanova, Marta Prieto, Ana I. Morales, Characterization of Renal Damage Associated with Oncologic Immunotherapy , FarmaJournal: Vol. 8 No. 1 (2023)
You may also start an advanced similarity search for this article.
Downloads
Download data is not yet available.
+
−